With 0.53 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.5 million shares. During the session, the Medical Instruments & Supplies company that operates in wider Healthcare sector, reached to the highest price of $34.11 whereas the lowest price it dropped to was $32.075. The 52-week range on ATRC shows that it touched its highest point at $39.04 and its lowest point at $18.94 during that stretch. It currently has a 1-year price target of $45.11. Beta for the stock currently stands at 1.43.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ATRC was up-trending over the past week, with a rise of 10.14%, but this was down by -1.72% over a month. Three-month performance surged to 23.21% while six-month performance rose 51.69%. The stock lost -3.91% in the past year, while it has gained 10.14% so far this year. A look at the trailing 12-month EPS for ATRC yields -0.83 with Next year EPS estimates of -0.64. For the next quarter, that number is -0.20. This implies an EPS growth rate of -23.82% for this year and 22.26% for next year. EPS is expected to grow by 20.00% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -1.17%.
Float and Shares Shorts:
At present, 48.75 million ATRC shares are outstanding with a float of 47.17 million shares on hand for trading. On 2024-12-13, short shares totaled 1.6 million, which was 328.0 higher than short shares on 1731628800. In addition to Mr. Michael H. Carrel as the firm’s CEO, President & Director, Mr. Douglas J. Seith serves as its Chief Operating Officer.
Institutional Ownership:
Through their ownership of 1.04321 of ATRC’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-09-30, ATRC reported revenue of $115910000.0 and operating income of -$7405000.0. The EBITDA in the recently reported quarter was -$936000.0 and diluted EPS was -$0.17.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ATRC since 4 analysts follow the stock currently. There are 4 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With ATRC analysts setting a high price target of 61.0 and a low target of 36.0, the average target price over the next 12 months is 45.11111. Based on these targets, ATRC could surge 81.22% to reach the target high and rise by 6.95% to reach the target low. Reaching the average price target will result in a growth of 34.02% from current levels.
Analysts have provided yearly estimates in a range of -$0.77243 being high and -$0.85079 being low. For ATRC, this leads to a yearly average estimate of -$0.81721.
